December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
From Waldencast plc
Via GlobeNewswire
Tickers WALD
News headline image
New Insurance Industry Report: Reduced Catastrophe Losses Drive Continued Industry Improvements
From Verisk Analytics, Inc.
Via GlobeNewswire
Tickers VRSK
News headline image
China and ASEAN Celebrate the Chinese Spring Festival Together
From The Information Office of the People's Government of Guangxi Zhuang Autonomous Region
Via GlobeNewswire
News headline image
Gauzy Ltd. Announces Receipt of Nasdaq Notice Regarding Board Composition Requirements
From GAUZY LTD
Via GlobeNewswire
Tickers GAUZ
News headline image
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Taysha Gene Therapies, Inc.
Via GlobeNewswire
Tickers TSHA
News headline image
Abercrombie & Fitch Co. to Report Fourth Quarter and Full Year 2025 Results on March 4, 2026
From Abercrombie & Fitch Management Co.
Via GlobeNewswire
Tickers ANF
News headline image
Hopebridge Announces Retirement of CEO Dennis May After a Decade of Leadership
From Hopebridge
Via GlobeNewswire
News headline image
Karat Packaging Board Declares Quarterly Cash Dividend
From Karat Packaging Inc.
Via GlobeNewswire
Tickers KRT
News headline image
ESET’s Chief Security Evangelist Tony Anscombe to Speak at NetDiligence Cyber Risk Summit
From ESET
Via GlobeNewswire
News headline image
Polyrizon Signs an Agreement to Develop Intranasal Proprietary Non-Hallucinogenic Neuroplastogen Formulation
From Polyrizon Ltd.
Via GlobeNewswire
Tickers CMND PLRZ
News headline image
Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI
From Clearmind Medicine Inc.
Via GlobeNewswire
Tickers CMND PLRZ
News headline image
Jeffs’ Brands: KeepZone AI Announces Exclusive Agreement for the Reselling of Counter Underwater Systems for Drug Smuggling and Protecting Offshore Assets
From Jeffs' Brands Ltd
Via GlobeNewswire
Tickers JFBR JFBRW
News headline image
Enwex ERCOT Onshore Wind Futures Now Live for Trading on Abaxx Exchange
From Abaxx Technologies Inc.
Via GlobeNewswire
Tickers ABXXF
News headline image
Brixton Metals Defines New Exploration Targets at Thorn Through Geochemical Sampling
From Brixton Metals Corporation
Via GlobeNewswire
Tickers BBBXF TSX-V:BBB
News headline image
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease
From uniQure Inc.
Via GlobeNewswire
Tickers QURE
News headline image
Marex Group plc to acquire equity derivatives market maker Webb Traders
From Marex Group plc
Via GlobeNewswire
Tickers MRX
News headline image
Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025
From Roivant Sciences
Via GlobeNewswire
Tickers ROIV
News headline image
Aurora Mobile’s EngageLab Partners with Blurams to Drive Global IoT Service Growth
From Aurora Mobile Limited
Via GlobeNewswire
Tickers JG
News headline image
Vine Hill Capital Investment Corp. II Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on February 9, 2026
From Vine Hill Capital Investment Corp. II
Via GlobeNewswire
Tickers VHCPU
News headline image
Cibus Partnering with The John Innes Centre for UK Government’s Farming Innovation Programme Precision Breeding Initiative
From Cibus US LLC
Via GlobeNewswire
Tickers CBUS
News headline image
Shoals Technologies Group, Inc. Announces Participation in Upcoming Events for the Investor Community
From Shoals Technologies Group
Via GlobeNewswire
Tickers SHLS
News headline image
Pulmovant Announces Completion of Enrollment in the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Pulmovant, Inc.
Via GlobeNewswire
Tickers ROIV
News headline image
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
From Roivant Sciences
Via GlobeNewswire
Tickers ROIV
News headline image
Bitfarms Announces U.S. Redomiciliation Plan and Intent to Rebrand as Keel Infrastructure
From Bitfarms Ltd.
Via GlobeNewswire
Tickers BITF TSX:BITF
News headline image
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter and Full Year 2025 Financial Results on February 20, 2026
From Balchem Corporation
Via GlobeNewswire
Tickers BCPC
News headline image
Perella Weinberg Reports Full Year and Fourth Quarter 2025 Results
From Perella Weinberg Partners Group LP
Via GlobeNewswire
Tickers PWP
News headline image
nVent Electric plc Fourth Quarter and Full Year 2025 Financial Results Available on Company’s Website
From nVent
Via GlobeNewswire
Tickers NVT
News headline image
Shell plc - Outcome of audit tender process
From Shell plc
Via GlobeNewswire
Tickers SHEL
News headline image
HUTCHMED to Announce 2025 Final Results
From HUTCHMED (China) Limited
Via GlobeNewswire
Tickers HCM LSE
News headline image
WINTOPAY and Shoplazza Forge Strategic Partnership to Deliver Seamless Local Acquiring Solutions, Featured on the Nasdaq Tower
From WINTOPAY
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.